KAREN H LU to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications KAREN H LU has written about Antineoplastic Agents, Immunological.
Connection Strength
0.113
-
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer. Int J Gynecol Cancer. 2020 11; 30(11):1733-1737.
Score: 0.093
-
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol. 2018 11; 151(2):374-380.
Score: 0.020